GNLX vs NVO
Genelux Corporation Common Stock (GNLX) versus NVO (NVO) — a side-by-side from cached financials, not a winner call.
Genelux Corporation Common Stock (GNLX) is a biotechnology company listed on US.
NVO (NVO) common stock.
Latest reported GNLX revenue for 2025-12-31 was $8.0K. Net income was -$32.1M. Revenue was up 0.0% from 2024-12-31 to 2025-12-31. GNLX currently screens at market cap $130.6M.
NVO does not have a complete income-statement cache yet.
GNLX currently screens at market cap $130.6M. NVO currently screens at market cap $0.
Not investment advice. Open the GNLX and NVO stock pages for the full models.
Not investment advice.